Acquired Bleeding Disorder, Trauma
Conditions
Brief summary
This study is conducted in North America. The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic brain injury.
Interventions
DRUGactivated recombinant human factor VII
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Ages Eligible for Study: 18 Years - 85 Years
Countries
Canada, United States
Outcome results
None listed